2024
DOI: 10.1016/j.ncrna.2024.02.013
|View full text |Cite
|
Sign up to set email alerts
|

Crosstalk between lncRNAs and Wnt/β-catenin signaling pathways in lung cancers: From cancer progression to therapeutic response

Ting Wu,
YiRan Dong,
XinZhi Yang
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 103 publications
(115 reference statements)
0
1
0
Order By: Relevance
“…Emerging evidence indicates that exosomal lncRNAs and circRNAs are influential modulators of lung cancer drug resistance. By transporting diverse drug-resistant biomolecules, these exosomal non-coding RNAs play critical roles in lung cancer development, metastatic recurrence, and chemotherapy resistance [ 42 , 79 ]. For instance, exosomal lncRNA FOXD3-AS1 enhances ELAVL1 expression, activating the PI3K/Akt pathway to fortify lung cancer cell proliferation, invasion, and 5-fluorouracil resistance [ 58 ].…”
Section: Insights Into the Exosomal Lncrnas And Circrnasmentioning
confidence: 99%
“…Emerging evidence indicates that exosomal lncRNAs and circRNAs are influential modulators of lung cancer drug resistance. By transporting diverse drug-resistant biomolecules, these exosomal non-coding RNAs play critical roles in lung cancer development, metastatic recurrence, and chemotherapy resistance [ 42 , 79 ]. For instance, exosomal lncRNA FOXD3-AS1 enhances ELAVL1 expression, activating the PI3K/Akt pathway to fortify lung cancer cell proliferation, invasion, and 5-fluorouracil resistance [ 58 ].…”
Section: Insights Into the Exosomal Lncrnas And Circrnasmentioning
confidence: 99%